Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.
These recommendations represent the first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of live, attenuated varicella virus vaccine--VARIVAX--manufactured by Merck and Company, Inc. and licensed in March 1995 for use in healthy persons > or = 12 months of age. In addition to presenting information regarding vaccine, this statement updates previous recommendations concerning the use of varicella zoster immune globulin (VZIG) as prophylaxis against varicella (MMWR 1984; 33:84-90, 95-100).
D000212:Acyclovir / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000368:Aged; D000914:Antibodies, Viral / Q000032:analysis; D000998:Antiviral Agents / Q000627:therapeutic use; D002644:Chickenpox / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control* / Q000635:transmission; D019433:Chickenpox Vaccine; D002648:Child; D002675:Child, Preschool; D000075202:Contraindications; D003362:Cost-Benefit Analysis; D003428:Cross Infection; D004356:Drug Storage; D005260:Female; D006562:Herpes Zoster / Q000276:immunology / Q000517:prevention & control / Q000635:transmission; D014645:Herpesvirus 3, Human / Q000276:immunology; D006801:Humans; D007106:Immune Sera / Q000008:administration & dosage / Q000009:adverse effects; D007116:Immunization, Passive / Q000592:standards; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D008875:Middle Aged; D011247:Pregnancy; D011358:Product Surveillance, Postmarketing; D012698:Serologic Tests; D014611:Vaccination / Q000009:adverse effects / Q000191:economics / Q000592:standards*; D014613:Vaccines, Attenuated; D014765:Viral Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000276:immunology / Q000600:supply & distribution
D000914:Antibodies, Viral; D000998:Antiviral Agents; D019433:Chickenpox Vaccine; D007106:Immune Sera; D014613:Vaccines, Attenuated; D014765:Viral Vaccines; C030799:varicella-zoster immune globulin; D000212:Acyclovir